PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.00 - 0.01
0.00 - 0.02
1.30M / 496.9K (Avg.)
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
100.00%
Growth of 100.00% while ECL.AX shows flat revenue. Bruce Berkowitz would examine growth quality advantage.
334.38%
Cost growth of 334.38% while ECL.AX maintains flat costs. Bruce Berkowitz would investigate efficiency gap.
-27.20%
Gross profit decline while ECL.AX shows 0.00% growth. Joel Greenblatt would examine competitive position.
-63.60%
Margin decline while ECL.AX shows 0.00% expansion. Joel Greenblatt would examine competitive position.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
G&A reduction while ECL.AX shows 0.00% growth. Joel Greenblatt would examine efficiency advantage.
100.00%
Marketing expense change of 100.00% while ECL.AX maintains spending. Bruce Berkowitz would investigate effectiveness.
No Data
No Data available this quarter, please select a different quarter.
-22.07%
Operating expenses reduction while ECL.AX shows 0.00% growth. Joel Greenblatt would examine advantage.
122.65%
Total costs change of 122.65% while ECL.AX maintains costs. Bruce Berkowitz would investigate control.
65.78%
Interest expense change of 65.78% while ECL.AX maintains costs. Bruce Berkowitz would investigate control.
100.00%
D&A change of 100.00% while ECL.AX maintains D&A. Bruce Berkowitz would investigate efficiency.
100.45%
EBITDA change of 100.45% while ECL.AX is flat. Bruce Berkowitz would examine quality.
-56.72%
EBITDA margin decline while ECL.AX shows 0.00% growth. Joel Greenblatt would examine position.
-47.00%
Operating income decline while ECL.AX shows 0.00% growth. Joel Greenblatt would examine position.
-73.50%
Operating margin decline while ECL.AX shows 0.00% growth. Joel Greenblatt would examine position.
-175.68%
Other expenses reduction while ECL.AX shows 0.00% growth. Joel Greenblatt would examine advantage.
100.00%
Income change of 100.00% while ECL.AX is flat. Bruce Berkowitz would examine quality.
No Data
No Data available this quarter, please select a different quarter.
100.00%
Tax expense change of 100.00% while ECL.AX maintains burden. Bruce Berkowitz would investigate strategy.
100.00%
Income change of 100.00% while ECL.AX is flat. Bruce Berkowitz would examine quality.
No Data
No Data available this quarter, please select a different quarter.
100.00%
EPS change of 100.00% while ECL.AX is flat. Bruce Berkowitz would examine quality.
100.00%
Diluted EPS change of 100.00% while ECL.AX is flat. Bruce Berkowitz would examine quality.
-7.26%
Share count reduction while ECL.AX shows 0.00% change. Joel Greenblatt would examine strategy.
-7.26%
Diluted share reduction while ECL.AX shows 0.00% change. Joel Greenblatt would examine strategy.